Form D · Biotechnology
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Pasadena, CA · CIK 0001335105
Offering snapshot reported Aug 1, 2023 · SEC filing
- Reported sold
- $3.5M Offering amount: $3.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $3.5M Reported outside-investor minimum
- First sale
- Jul 20, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 1, 2023 | Initial | $3,500,000 | No comparison | 1 | SEC filing |
| Dec 12, 2018 | Initial | $4,500,000 | No comparison | 15 | SEC filing |
| Jan 27, 2010 | Initial | $1,787,500 | No comparison | 14 | SEC filing |
| Apr 13, 2009 | Amendment | $710,000 | No comparison | Not reported | SEC filing |
| Feb 18, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 4, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $210K
- Finders' fees
- $0
- Form D file number
- 021-488474
The common stock warrants being offered hereunder are being offered as part of a broader offering which includes the public sale of shares of common stock and pre-funded warrants. The total offering amount is $3,500,000.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| A.G.P. / ALLIANCE GLOBAL PARTNERS | 8361 |
Source: Form D, filed Aug 1, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rene Bernards | Director |
| Regina Brown | Director |
| Stephen K. Carter | Director |
| Stephen Forman | Director |
| Eric Forman | Executive |
| Winson (Sze Chun) Ho | Director |
| John Kovach | Director, Executive |
| James Miser | Executive |
| Philip Palmedo | Director |
| Mel Sorenson | Director |
| Bas Van Der Baan | Director |
| Robert Weingarten | Executive |
| Yun Yen | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
680 East Colorado Boulevard Suite 180
Pasadena, CA, 11733
Pasadena, CA, 11733